In April last year, Humedica raised $33m in its series C round from a consortium including local drugs maker Merck.
UnitedHealth Group has acquired Humedica, a US-based clinical intelligence company for healthcare providers backed by Merck and Allscripts’ corporate venturing units, for $165m, according to a deal insider.
In April last year, Humedica raised $33m in its series C round from a consortium including local drugs maker Merck.
In May 2011, Nasdaq-listed healthcare provider Allscripts made a strategic investment in Humedica “to enhance its existing portfolio of analytics solutions and address a fundamental shift in the way healthcare providers are paid”.
Allscripts joined existing Humedica investors Bain Capital Ventures, General Catalyst Partners, North Bridge Venture Partners and Leerink Swann.
In 2008, Humedica raised $29.5m.
